Cellectis Plans to Conduct Registered Initial Public Offering in the U.S.
Published on January 08, 2015
Paris, January 8 - Cellectis SA (Alternext: ALCLS.PA) announced today that it plans to conduct a registered initial public offering in the United States.
The timing, number of shares and price of the proposed offering have not yet been determined.
This announcement is being made pursuant to and in accordance with Rule 135 under the Securities Act of 1933. As required by Rule 135, this press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.